Recursion vs Semrush One
Side-by-side comparison of features, pricing, and ratings
At a glance
| Dimension | Recursion | Semrush One |
|---|---|---|
| Core Focus | Drug discovery via phenomics AI | SEO & AI search visibility |
| Pricing | Contact sales (custom enterprise) | Paid plans (enterprise-tier) |
| Key Dataset | 50+ petabytes phenomics, transcriptomics, etc. | 28B+ keywords, 43T backlinks, 289M+ LLM prompts |
| Hardware/Infrastructure | NVIDIA BioHive-2 supercomputer, automated wet lab | Cloud-based SaaS, no dedicated hardware |
| Integrations | NVIDIA, BioHive-2 | ChatGPT, Adobe, Google Analytics, Shopify, WordPress, etc. |
| Best For | Pharma & biotech R&D | Enterprise marketing & SEO teams |
These tools are incomparable: Recursion is a techbio platform for drug discovery with custom pricing and a massive wet lab, while Semrush One is a SaaS for SEO and AI search visibility with fixed enterprise pricing. Your choice depends entirely on your domain—biotech vs. digital marketing. Neither is a substitute for the other; pick Recursion if you're a pharma company seeking novel therapeutics, or Semrush One if you need to optimize brand presence across traditional and AI search.
AI drug discovery engine pairing 2M weekly wet-lab experiments with a 50+ petabyte phenomics dataset
Visit Website
Unified SEO and AI search visibility platform that tracks how your brand appears in Google and in LLM answers.
Visit WebsiteWhat real users say: Recursion vs Semrush One
Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.
Recursion
68 mentions across 4 sources · 45% positive — mixed (averaged across 4 sources)
Reddit, Hacker News, Stack Overflow, Lemmy
What users praise
- • Massive dataset integration (50+ petabytes) for deep biological insights
- • Automated wet lab enables millions of experiments weekly, accelerating discovery
- • Strategic NVIDIA partnership provides cutting-edge compute power
- • Multiple clinical trials with early positive data validate approach
What frustrates them
- • Highly complex platform requires advanced technical expertise to use
- • Proprietary algorithms and data limit external validation and trust
- • Clinical success still unproven; most programs in early phases
- • High cost likely restricts access to well-funded organizations
Researched Jul 31, 2026
Semrush One
25 mentions across 3 sources · 43% positive — mixed (averaged across 3 sources)
YouTube, Bluesky, Lemmy
What users praise
- • Large 28B keyword and 43T backlink databases for deep research.
- • Unique AI visibility tracking across 289M+ LLM prompts.
- • All-in-one platform reduces need for multiple SEO tools.
- • Integrates with Adobe for agentic brand visibility workflows.
What frustrates them
- • Higher cost than dedicated AI visibility tools like AIClicks.
- • Steep learning curve for AI features beyond classic SEO.
- • Some reviews are dismissed as commercials, not honest.
- • Annual contract lock-in concerns for testing the tool.
Researched Jul 16, 2026
Who should pick which
- Pharma R&D VPPick: Recursion
Accelerate early-stage drug discovery with Recursion's phenomics platform, automated wet lab, and clinical pipeline—ideal for reducing failure rates in oncology and rare diseases.
- Enterprise SEO DirectorPick: Semrush One
Semrush One provides comprehensive AI and traditional search visibility tracking, keyword research, and integrations with Adobe and ChatGPT—exactly what enterprise marketing needs.
- Biotech InvestorPick: Recursion
Evaluate Recursion's clinical assets (like REC-4881) and AI-driven pipeline for investment opportunities in techbio.
- Digital Agency OwnerPick: Semrush One
Manage multi-client SEO, social, and ad campaigns with Semrush One's unified platform, including AI PR module and competitor analysis.
- Rare Disease ResearcherPick: Recursion
Leverage Recursion's large-scale phenotypic data and machine learning for novel target identification and molecule design in rare diseases.
Frequently Asked Questions
Recursion vs Semrush One: which should you choose?
These tools are incomparable: Recursion is a techbio platform for drug discovery with custom pricing and a massive wet lab, while Semrush One is a SaaS for SEO and AI search visibility with fixed enterprise pricing. Your choice depends entirely on your domain—biotech vs. digital marketing. Neither is a substitute for the other; pick Recursion if you're a pharma company seeking novel therapeutics, or Semrush One if you need to optimize brand presence across traditional and AI search.
Can Semrush One help with drug discovery?
No, Semrush One is designed for marketing and SEO, not drug development.
Does Recursion offer a software subscription for SEO?
No, Recursion is a techbio company focused on drug discovery; it does not provide marketing analytics.
Which tool integrates with ChatGPT?
Semrush One integrates with ChatGPT via MCP access; no such integration is listed for Recursion.
What is the latest news about Recursion's clinical trials?
Recursion reported positive Phase 1b/2 results for REC-4881 in advanced solid tumors and dosed first patient for REC-3565; both are in oncology.
Does Semrush One track AI search visibility?
Yes, it tracks brand presence across 289M+ LLM prompts, including AI Overviews and AI Mode.
Is Recursion suitable for a startup on a budget?
No, Recursion's custom pricing and partnership model are geared toward large pharma; it's not for small-scale use.
Can I use Semrush One for technical SEO audits?
Yes, Semrush One includes technical SEO audits and site health monitoring.
Which tool has its own supercomputer?
Recursion uses the NVIDIA BioHive-2 supercomputer for AI model training; Semrush One is a SaaS with no dedicated hardware.
More Recursion or Semrush One comparisons
If you're a pharma company aiming to slash drug failure rates, Recursion's integrated platform and clinical assets are unmatched, but it requires deep partnership and investment. For personal mental w
If you're a pharma company looking to accelerate early-stage drug discovery with a platform that combines massive phenomics data, automated wet labs, and AI modeling, Recursion is your choice. For lar
If you're a content marketer or agency cranking out SEO blog briefs from competitor data, Contenov's freemium model and focused brief generation win hands-down for speed and price. For enterprise team
Recursion and Juno serve entirely different needs. Recursion is a high-investment platform for pharmaceutical companies aiming to accelerate drug discovery with massive datasets and wet-lab validation
Saama and Semrush One serve entirely different markets: Saama is a specialized clinical analytics platform for pharma and CROs, while Semrush One is a broad SEO and AI search visibility suite for ente
If you sell on Etsy and need real sales data to pick winning products, EverBee is a no-brainer at a low price. For enterprises managing brand visibility across Google, AI answers, social, and ads, Sem
Explore each tool further
Browse these categories
One email a week — new tools, honest comparisons, no spam.
Last reviewed: July 30, 2026